Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Acute heart failure and early development of left ventricular dysfunction in patients with ST segment elevation acute myocardial infarction managed with primary percutaneous coronary intervention].
Parenica J, Kala P, Jarkovský J, Poloczek M, Toman O, Goldbergová MP, Manousek J, Prymusová K, Kubková L, Tesák M, Elbl L, Cermáková Z, Spinar J. Parenica J, et al. Among authors: tesak m. Vnitr Lek. 2011 Jan;57(1):43-51. Vnitr Lek. 2011. PMID: 21351662 Czech.
ACE gene insertion/deletion polymorphism has a mild influence on the acute development of left ventricular dysfunction in patients with ST elevation myocardial infarction treated with primary PCI.
Parenica J, Goldbergova MP, Kala P, Jarkovsky J, Poloczek M, Manousek J, Prymusova K, Kubkova L, Tomcikova D, Toman O, Tesak M, Tomandl J, Vasku A, Spinar J. Parenica J, et al. Among authors: tesak m. BMC Cardiovasc Disord. 2010 Dec 17;10:60. doi: 10.1186/1471-2261-10-60. BMC Cardiovasc Disord. 2010. PMID: 21162760 Free PMC article.
The association between levels of tissue inhibitor of metalloproteinase-1 with acute heart failure and left ventricular dysfunction in patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention.
Goldbergova MP, Parenica J, Jarkovsky J, Kala P, Poloczek M, Manousek J, Kluz K, Kubkova L, Littnerova S, Tesak M, Toman O, Pavek N, Cermakova Z, Tomandl J, Vasku A, Spinar J. Goldbergova MP, et al. Among authors: tesak m. Genet Test Mol Biomarkers. 2012 Oct;16(10):1172-8. doi: 10.1089/gtmb.2012.0120. Epub 2012 Sep 12. Genet Test Mol Biomarkers. 2012. PMID: 22971139 Free PMC article.
Unstable angina pectoris prior to ST elevation myocardial infarction in patients treated with primary percutaneous coronary intervention has no influence on prognosis.
Kluz K, Parenica J, Kubkova L, Littnerova S, Tomandl J, Poloczek M, Toman O, Tesak M, Cermakova Z, Gottwaldova J, Manousek J, Pavkova Goldbergova M, Spinar J, Jarkovsky J. Kluz K, et al. Among authors: tesak m. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Jun;159(2):251-8. doi: 10.5507/bp.2014.003. Epub 2014 Jan 23. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015. PMID: 24457834 Free article.
GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction.
Littnerova S, Kala P, Jarkovsky J, Kubkova L, Prymusova K, Kubena P, Tesak M, Toman O, Poloczek M, Spinar J, Dusek L, Parenica J. Littnerova S, et al. Among authors: tesak m. PLoS One. 2015 Apr 20;10(4):e0123215. doi: 10.1371/journal.pone.0123215. eCollection 2015. PLoS One. 2015. PMID: 25893501 Free PMC article.
Activation of the Nitric Oxide Pathway and Acute Myocardial Infarction Complicated by Acute Kidney Injury.
Parenica J, Kala P, Mebazaa A, Littnerova S, Benesova K, Tomandl J, Goldbergová Pavkova M, Jarkovský J, Spinar J, Tomandlova M, Dastych M, Ince C, Helanova K, Tesak M, Helan M, Lokaj P, Legrand M; GREAT Network. Parenica J, et al. Among authors: tesak m. Cardiorenal Med. 2020;10(2):85-96. doi: 10.1159/000503718. Epub 2020 Jan 20. Cardiorenal Med. 2020. PMID: 31958795
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators. Anand SS, et al. Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10. Lancet. 2018. PMID: 29132880 Free article. Clinical Trial.
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
Connolly SJ, Eikelboom JW, Bosch J, Dagenais G, Dyal L, Lanas F, Metsarinne K, O'Donnell M, Dans AL, Ha JW, Parkhomenko AN, Avezum AA, Lonn E, Lisheng L, Torp-Pedersen C, Widimsky P, Maggioni AP, Felix C, Keltai K, Hori M, Yusoff K, Guzik TJ, Bhatt DL, Branch KRH, Cook Bruns N, Berkowitz SD, Anand SS, Varigos JD, Fox KAA, Yusuf S; COMPASS investigators. Connolly SJ, et al. Lancet. 2018 Jan 20;391(10117):205-218. doi: 10.1016/S0140-6736(17)32458-3. Epub 2017 Nov 10. Lancet. 2018. PMID: 29132879 Clinical Trial.
12 results